Suppr超能文献

Lkb1 和 Pten 的缺失导致肺鳞状细胞癌,并伴有 PD-L1 表达升高。

Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

机构信息

Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Belfer Institute For Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Cancer Cell. 2014 May 12;25(5):590-604. doi: 10.1016/j.ccr.2014.03.033. Epub 2014 May 1.

Abstract

Lung squamous cell carcinoma (SCC) is a deadly disease for which current treatments are inadequate. We demonstrate that biallelic inactivation of Lkb1 and Pten in the mouse lung leads to SCC that recapitulates the histology, gene expression, and microenvironment found in human disease. Lkb1;Pten null (LP) tumors expressed the squamous markers KRT5, p63 and SOX2, and transcriptionally resembled the basal subtype of human SCC. In contrast to mouse adenocarcinomas, the LP tumors contained immune populations enriched for tumor-associated neutrophils. SCA1(+)NGFR(+) fractions were enriched for tumor-propagating cells (TPCs) that could serially transplant the disease in orthotopic assays. TPCs in the LP model and NGFR(+) cells in human SCCs highly expressed Pd-ligand-1 (PD-L1), suggesting a mechanism of immune escape for TPCs.

摘要

肺鳞状细胞癌(SCC)是一种致命的疾病,目前的治疗方法还不够完善。我们证明,在小鼠肺部中 Lkb1 和 Pten 的双等位基因失活会导致 SCC,其重现了在人类疾病中发现的组织学、基因表达和微环境。Lkb1;Pten 缺失(LP)肿瘤表达鳞状标记物 KRT5、p63 和 SOX2,并且在转录上类似于人类 SCC 的基底亚型。与小鼠腺癌不同,LP 肿瘤中富含富含肿瘤相关中性粒细胞的免疫群体。SCA1(+)NGFR(+) 分数富含能够在原位测定中连续移植疾病的肿瘤起始细胞(TPCs)。LP 模型中的 TPCs 和人类 SCC 中的 NGFR(+) 细胞高度表达 PD-配体-1(PD-L1),这表明 TPCs 免疫逃逸的一种机制。

相似文献

1
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.
Cancer Cell. 2014 May 12;25(5):590-604. doi: 10.1016/j.ccr.2014.03.033. Epub 2014 May 1.
2
Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2764-2769. doi: 10.1016/j.bbrc.2018.08.037. Epub 2018 Aug 9.
3
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
J Thorac Oncol. 2017 Jun;12(6):943-953. doi: 10.1016/j.jtho.2017.03.010. Epub 2017 Mar 21.
8
CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
Int Immunopharmacol. 2020 Nov;88:106864. doi: 10.1016/j.intimp.2020.106864. Epub 2020 Aug 28.
9
Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer.
Cell Rep. 2014 Jul 10;8(1):40-9. doi: 10.1016/j.celrep.2014.05.036. Epub 2014 Jun 19.

引用本文的文献

1
Involvement of KEAP1/NRF2 pathway in non-BRAF mutated squamous cell carcinoma of the thyroid.
J Pathol. 2025 Aug;266(4-5):481-494. doi: 10.1002/path.6444. Epub 2025 Jul 2.
2
KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer.
bioRxiv. 2025 Mar 13:2025.03.10.641898. doi: 10.1101/2025.03.10.641898.
3
Glycogen drives tumour initiation and progression in lung adenocarcinoma.
Nat Metab. 2025 Mar 11. doi: 10.1038/s42255-025-01243-8.
4
Comprehensive discovery and functional characterization of the noncanonical proteome.
Cell Res. 2025 Mar;35(3):186-204. doi: 10.1038/s41422-024-01059-3. Epub 2025 Jan 10.
5
Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control.
Front Med. 2025 Feb;19(1):23-52. doi: 10.1007/s11684-024-1107-1. Epub 2025 Jan 2.
6
Insights into targeting LKB1 in tumorigenesis.
Genes Dis. 2024 Aug 28;12(2):101402. doi: 10.1016/j.gendis.2024.101402. eCollection 2025 Mar.
7
The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression.
Front Cell Dev Biol. 2024 Oct 31;12:1449543. doi: 10.3389/fcell.2024.1449543. eCollection 2024.
8
Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma.
Cancer Drug Resist. 2024 Oct 31;7:42. doi: 10.20517/cdr.2024.54. eCollection 2024.
9
Molecular and cellular dynamics of squamous cell carcinomas across tissues.
Genes Dev. 2025 Jan 7;39(1-2):18-35. doi: 10.1101/gad.351990.124.
10
Using 3-Dimensional Cultures to Propagate Genetically Modified Lung Organoids.
Methods Mol Biol. 2024;2805:19-30. doi: 10.1007/978-1-0716-3854-5_2.

本文引用的文献

2
Natural and induced T regulatory cells in cancer.
Front Immunol. 2013 Jul 11;4:190. doi: 10.3389/fimmu.2013.00190. eCollection 2013.
3
Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation.
Blood. 2013 Jun 13;121(24):4930-7. doi: 10.1182/blood-2013-02-486217. Epub 2013 May 3.
4
Role of PTEN in basal cell derived lung carcinogenesis.
Mol Carcinog. 2014 Oct;53(10):841-6. doi: 10.1002/mc.22030. Epub 2013 Apr 26.
5
The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.
Cancer Cell. 2013 Apr 15;23(4):527-40. doi: 10.1016/j.ccr.2013.03.009.
6
Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.
Semin Cancer Biol. 2013 Jun;23(3):141-8. doi: 10.1016/j.semcancer.2013.02.005. Epub 2013 Feb 26.
8
Cancer statistics, 2013.
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
9
Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
Oncogene. 2013 Sep 12;32(37):4436-47. doi: 10.1038/onc.2012.444. Epub 2012 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验